PT562. Alzheimer disease therapeutics candidate, SAK3 improves the cognitive functions through inhibition of amyloid beta accumulation in APP23 mice.

Detalles Bibliográficos
Autores principales: Izumi, ○Hisanao, Yasushi, Yabuki, Shinoda, Yasuharu, Kohji, Fukunaga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616896/
http://dx.doi.org/10.1093/ijnp/pyw044.562
_version_ 1783266890807771136
author Izumi, ○Hisanao
Yasushi, Yabuki
Shinoda, Yasuharu
Kohji, Fukunaga
author_facet Izumi, ○Hisanao
Yasushi, Yabuki
Shinoda, Yasuharu
Kohji, Fukunaga
author_sort Izumi, ○Hisanao
collection PubMed
description
format Online
Article
Text
id pubmed-5616896
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56168962017-11-27 PT562. Alzheimer disease therapeutics candidate, SAK3 improves the cognitive functions through inhibition of amyloid beta accumulation in APP23 mice. Izumi, ○Hisanao Yasushi, Yabuki Shinoda, Yasuharu Kohji, Fukunaga Int J Neuropsychopharmacol Abstracts Oxford University Press 2016-05-27 /pmc/articles/PMC5616896/ http://dx.doi.org/10.1093/ijnp/pyw044.562 Text en © The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
spellingShingle Abstracts
Izumi, ○Hisanao
Yasushi, Yabuki
Shinoda, Yasuharu
Kohji, Fukunaga
PT562. Alzheimer disease therapeutics candidate, SAK3 improves the cognitive functions through inhibition of amyloid beta accumulation in APP23 mice.
title PT562. Alzheimer disease therapeutics candidate, SAK3 improves the cognitive functions through inhibition of amyloid beta accumulation in APP23 mice.
title_full PT562. Alzheimer disease therapeutics candidate, SAK3 improves the cognitive functions through inhibition of amyloid beta accumulation in APP23 mice.
title_fullStr PT562. Alzheimer disease therapeutics candidate, SAK3 improves the cognitive functions through inhibition of amyloid beta accumulation in APP23 mice.
title_full_unstemmed PT562. Alzheimer disease therapeutics candidate, SAK3 improves the cognitive functions through inhibition of amyloid beta accumulation in APP23 mice.
title_short PT562. Alzheimer disease therapeutics candidate, SAK3 improves the cognitive functions through inhibition of amyloid beta accumulation in APP23 mice.
title_sort pt562. alzheimer disease therapeutics candidate, sak3 improves the cognitive functions through inhibition of amyloid beta accumulation in app23 mice.
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616896/
http://dx.doi.org/10.1093/ijnp/pyw044.562
work_keys_str_mv AT izumihisanao pt562alzheimerdiseasetherapeuticscandidatesak3improvesthecognitivefunctionsthroughinhibitionofamyloidbetaaccumulationinapp23mice
AT yasushiyabuki pt562alzheimerdiseasetherapeuticscandidatesak3improvesthecognitivefunctionsthroughinhibitionofamyloidbetaaccumulationinapp23mice
AT shinodayasuharu pt562alzheimerdiseasetherapeuticscandidatesak3improvesthecognitivefunctionsthroughinhibitionofamyloidbetaaccumulationinapp23mice
AT kohjifukunaga pt562alzheimerdiseasetherapeuticscandidatesak3improvesthecognitivefunctionsthroughinhibitionofamyloidbetaaccumulationinapp23mice

Ejemplares similares